GSK Seeks Approval for World's First Malaria Vaccine

GlaxoSmithKline said on Thursday it is applying for regulatory approval for the world's first vaccine against malaria, designed for children in Africa. The British drugmaker said the shot -- called RTS,S -- is intended exclusively for use outside the European Union but will be evaluated by the European Medicines Agency [EMA] in collaboration with the World Health Organization [WHO]. Malaria, a mosquito-borne parasitic disease, kills more than 600,000 people a year, mainly babies in...

© La Voix de l'Amérique - jeudi 24 juillet 2014